Komori
Changes in Officers130AVeritas In Silico Inc.Pharmaceuticals

Notice of Changes in Executive Officers

The responsibilities of the executive officers will change, and Sasaki Jun (佐々木 潤) will become Head of the Research Strategy Department and Head of the New Business Development Office. Sasakawa Tatsuya (笹川 達也) will retire as an executive officer.

Worth reading
25Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Who is moving to which position

Resolved 13 July 2026

Incoming appointee

1 item
Scheduled Appointment DateEffective 13 July 2026
Sasaki Jun (佐々木 潤)
Previous positionHead of the New Business Development Office
New positionExecutive Officer, Head of the Research Strategy Department and Head of the New Business Development Office

Departing officer

1 item
Date of departureEffective 13 July 2026
Sasakawa Tatsuya (笹川 達也)Next role stated
Former PositionExecutive Officer and Head of the Research Strategy Department
New position(Retirement)

“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.

Whether the incumbent will remain in office (whether they will retain their position)

Appears not to remain on the Board of Directors

Who is moving to which position
ItemDetails
Resolution date13 July 2026
Scheduled Appointment DateEffective 13 July 2026
Date of departureEffective 13 July 2026
Name of appointeeSasaki Jun (佐々木 潤)
Appointee's new positionExecutive Officer, Head of the Research Strategy Department and Head of the New Business Development Office
Appointee's previous positionHead of the New Business Development Office
Name of departing officerSasakawa Tatsuya (笹川 達也)
Former position of departing officerExecutive Officer and Head of the Research Strategy Department
New position of departing officer(Retirement)
Whether the incumbent will remain in officeAppears not to remain on the Board of Directors
Items this document does not state (11)
Appointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeReason for departureReason for changeReasons for appointmentNumber of directors after the changeFiling as an independent officerDetails of organizational changesChange in Corporate Governance StructureSubject to Approval by the General Meeting of Shareholders

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

No reason for the changes is provided.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Changes in Executive Officers | Veritas In Silico Inc. (130A) timely disclosure | Komori